Setbone Medical

Company Overview

Snapshot

Founded in December 2017 by Royi Kaufmann and Nimrod Kaufmann, Setbone Medical operates with 1–10 employees. The company has raised $1.6 million across two funding rounds from four investors, with The Trendlines Group participating in both rounds. In January 2022, SetBone Medical announced a $1.6 million financing round.

Business overview

Setbone Medical is a Health Tech & Life Sciences company developing a novel bone cement for treating vertebral compression fractures (VCF) primarily caused by osteoporosis. Its proprietary acrylic bone cement is designed to overcome limitations of current cements, offering physicians a safer and more efficient solution. The cement does not contain toxic monomers, comes in a ready-to-use, prefilled cartridge, and features dual-paste, mix-on injection for extended working time and a low exothermic reaction to prevent tissue damage. The company operates in the medical technologies sector, targeting global markets with its Setbone Cement product, which is currently in clinical trials.

Strategic signal

In January 2022, SetBone Medical announced a $1.6 million financing, signaling continued investor confidence in its novel bone cement technology. This funding supports the ongoing development and clinical trials of its proprietary acrylic bone cement, which aims to address the limitations of existing treatments for vertebral compression fractures. The investment highlights the market's interest in innovative solutions within the biomaterials and tissue engineering space, particularly those focused on improving patient safety and physician efficiency.

Company Intelligence Q&A

When was Setbone Medical founded?

Setbone Medical was founded in December 2017 by Royi Kaufmann and Nimrod Kaufmann.

What is Setbone Medical's primary focus?

Setbone Medical focuses on developing a novel bone cement for the treatment of vertebral compression fractures (VCF) primarily caused by osteoporosis.

What was a significant funding event for Setbone Medical?

In January 2022, SetBone Medical announced a $1.6 million financing round. The Trendlines Group and Chicago ArchAngels were among the investors.

What are the key features of Setbone Medical's bone cement?

Setbone Medical's bone cement does not contain toxic monomers, comes in a ready-to-use, prefilled cartridge, and offers a dual-paste, mix-on injection for extended working time and a low exothermic reaction to prevent tissue damage.

Which investor has participated in multiple funding rounds for Setbone Medical?

The Trendlines Group has participated in multiple funding rounds for Setbone Medical, including the seed round in December 2017 and the financing round in January 2022.